Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 2, 2006, Pages 344-348

  Uzunovic Kamberovic, Selma ^a  

^a Cantonal Public Health Institution Zenica   (Bosnia and Herzegovina)

Author keywords

Escherichia coli; Surveillance; Susceptibility testing

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFAZOLIN; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BOSNIA AND HERZEGOVINA; CHILD; CITROBACTER; COLIFORM BACTERIUM; CONTROLLED STUDY; DEMOGRAPHY; DIFFUSION; EMPIRICISM; ENTEROBACTER; ESCHERICHIA COLI; FEMALE; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEUS; SEX DIFFERENCE; URINALYSIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BOSNIA-HERZEGOVINA; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; URINARY TRACT INFECTIONS;

EID: 33748048150     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl243     Document Type: Article

References (38)

1. Oteo J, Aracil B, Hoyo JF et al. Do the quinolones still constitute valid empirical therapy for community-acquired urinary tract infections in Spain? Clin Microbiol Infect 1999; 5: 654-6.
2. Kahlmeter G. The ECO.SENS Project: A prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J Antimicrob Chemother 2000; 46 Suppl 1: 15-22.
3. Zhanel GG, Karlowsky JA, Harding GKM et al. A Canadian national surveillance study of urinary tract isolates from outpatients: comparision of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. Antimicrob Agents Chemother 2000; 44: 1089-92.
4. Ahmed AA, Osman H, Mansour AM et al. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am J Trop Med Hyg 2000; 63: 259-63.
5. Alós JI, Serrano M-G, Gómez-Garcés JL et al. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 2005; 11: 199-203.
6. Junquera S, Loza E, Baquero F. Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections. Enferm Infecc Microbiol Clin 2005; 23: 197-201.
7. Gales AC, Jones RN, Gordon KA et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: Report from second year of the SENTRY Antimicrobial Surveillance Program (1998). J Antimicrob Chemother 2000; 45: 295-303.
8. Acar JF, Goldsein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997; 24 Suppl 1: S67-73.
9. Grude N, Tveten Y, Kristiansen B-E. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates. Clin Microbiol Infect 2001; 7: 543-7.
10. Magee JT, Pritchard EL, Fitzgerald KA et al. Antibiotic prescribing and antibiotic resistance in community practice: Retrospective study, 1996-98. Br Med J 1998; 319: 1239-40.
11. Batchelor BIF, Crook DWM, Jones T et al. Impact of guidelines for diagnosis of urinary tract infection on trimethoprim susceptibility of Escherichia coli. J Antimicrob Chemother 2002; 49: 223-4.
12. Kelly MT, Brenner DJ, Farmer JJ. Enterobacteriaceae. In: Balows A, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, Murray PR, eds. Manual of Clinical Microbiology. Washington, DC, USA: ASM Press, 1995; 263-77.
13. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement M100-S12. NCCLS, Wayne, PA, USA, 2002.
14. Gupta K, Sahm D, Mayfield D et al. Antimicrobial resistance among uropathogens that cause community/acquired urinary tract infections in women: A nationwide analysis. Clin Infect Dis 2001; 33: 89-94.
15. Ti TY, Kumarasinghe G, Taylor MB et al. What is true community-acquired infection? Comparision of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis 2003; 22: 242-5.
16. Prais D, Straussberg R, Avitzur Y et al. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infections. Arch Dis Child 2003; 88: 215-8.
17. Barrett SP, Savage MA, Rebec MP et al. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infections in Britain. J Antimicrob Chemother 1999; 44: 359-65.
18. Aspevall O, Hallander H, Gant V et al. European guidelines for urinalysis: A collaborative document produced by European clinical microbiologists and clinical chemists under ECLM in collaboration with ESCMID. Clin Microbiol Infect 2001; 7: 173-8.
19. Hryniewicz K, Szczypa K, Sulikowska A et al. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 2001; 47: 773-80.
20. Howard AJ, Magee JT, Karen A et al. Factors associated with antibiotic resistance in coliform organisms from community urinary tract infections in Wales. J Antomicrob Chemother 2001; 47: 305-13.
21. Huovinen P. Recording of antimicrobial resistances of urinary tract isolates - effect of repeat samples on resistance levels. J Antimicrob Chemother 1985; 16: 443-7.
22. Barnett BJ, Stephens DS. Urinary tract infections: An overview. Am J Med Sci 314: 245-9.
23. Goettisch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in E. coli from urinary tract infections in The Netherlands. J Antimicrob Chemother 2000; 46: 223-8.
24. Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 2003; 52: 128-31.
25. Dimitrov TS, Udo EE, Emara M et al. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital. Med Princ Pract 2004; 13: 334-9.
26. Gupta K, Scholes D, Stamm W. Increaing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281: 736-8.
27. Livermoore DM, Stephens P, Weinberg J et al. Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antimicrobial prescribing. J Antimicrob Chemother 2000; 46: 411-22.
28. Steinke DT, Seaton RA, Phillips G et al. Prior trimethoprim use and trimetoprim-resistant urinary tract infection: A nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001; 47: 781-7
29. Cizman M, Orazem A, Krizan-Hergout V et al. Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections. J Antimicrob Chemother 2001; 47: 502.
30. Svetlansky I, Liskova A, Foltan V et al. Increased consumption of fluoroquinolones is not associated with resistance in Escherichia coli and Staphylococcus aureus in the community. J Antimicrob Chemother 2001; 48: 457-8.
31. Ishihara S, Yokoi S, Masue N et al. Urinary tract-derived Escherichia coli resistant to cotrimoxazole in Japan, where the drug is seldom used for treating acute urinary tract infections. J Antimicrob Chempther 2002; 49: 881-2.
32. Lazarevic G, Petreska D, Pavlovic S. Antibiotic sensitivity of bacteria isolated from the urine of children with urinary tract infections from 1985 to 1995. Srp Arh Celok Lek 1998; 126: 423-9.
33. Kunin CM, Lipton HL, Tupasi T et al. Social, behavioral, and practical factors affecting antibiotic use worldwide: Report of Task Force 4. Rev Infect Dis 1987; 9 Suppl 3: S270-85.
34. Uzunovic-Kamberovic S. Some epidemiologic features of Campylobacter jejuni/coli infections in Bosnia and Herzegovina after the war. Clin Microbiol Infect 2003; 9: 458-60.
35. Stamm WE. An epidemic of urinary tract infections? N Engl J Med 2001; 345: 1055-7.
36. Sahm DF, Thornsberry C, Mayfield DC et al. Multidrug-resistant urinary tract isolates of Escherichia coli: Prevalence and patient demographics in the United States in 2000. Antimicrob Agents Chemother 2001; 45: 1402-6.
37. Steinke D, Emslie-Smith A, Boyle P et al. A population study of first exposure to community antibacterials in children and the suitabilility of routine urine samples for study of the acquisition of drug resistance. J Antimicrob Chemother 2002; 50: 185-8.
38. Hillier SL, Magee JT, Howard AJ et al. How strong is the evidence that antibiotic use is a risk factor for antibiotic-resistant, community-acquired urinary tract infection? J Antimicrob Chemother 2002; 50: 241-7.